The effect of Diode micropulse laser on acute central serous chorioretinopathy in comparing to control group in patients of Isfahan Feiz hospital in 2016-2017

The effect of Diode micropulse laser on acute central serous chorioretinopathy in comparing to control group in patients of Isfahan Feiz hospital

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171030037087N1

Enrollment

Registered

2017-12-24

Start date

2017-03-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Central Serous Chorioretinopathy. Central serous chorioretinopathy Detachment of retinal pigment epithelium

Interventions

Intervention 1: intervention group: After obtaining written consent, diode micropulse laser with the power of 800 to 950 millivolt and With 810 nm pulses will be used for 0.1 to 0.3 second. Intervent

Treatment - Devices

intervention group: After obtaining written consent, diode micropulse laser with the power of 800 to 950 millivolt and With 810 nm pulses will be used for 0.1 to 0.3 second.

Control group: Patients are tracked for three months without taking medication and simulating.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: over 18 years old Informed consent to participate in research No any ocular pathology such as glaucoma no retinal hemorrhage Leakage on Fluorescein Angiography at a distance of more than 500 microns from fovea onset of acute central serous chorioretinopathy in one month after the first visit no Optic Neuritis

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in research Changing the diagnosis of the disease in the next stages of the study Failure to follow-up examinations

Design outcomes

Primary

Measure	Time frame
Average visual acuity. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With Snellen chart and then converted to LogMAR.;The mean of central macular volume. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With optical coherence tomography (OCT) imaging technique (Microns).;The mean of central macular thickness. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With optical coherence tomography (OCT) imaging technique (Microns).	—

Measure

Time frame

Average visual acuity. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With Snellen chart and then converted to LogMAR.;The mean of central macular volume. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With optical coherence tomography (OCT) imaging technique (Microns).;The mean of central macular thickness. Timepoint: The beginning and 1 month and 3 month after intervention. Method of measurement: With optical coherence tomography (OCT) imaging technique (Microns).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmid Pirhaji

Isfahan University of Medical Sciences

pirhaji.omid@yahoo.com+98 31 3624 6171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026